These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 8851250)
1. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)]. Verweij AM Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250 [TBL] [Abstract][Full Text] [Related]
2. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). Kalasinsky KS; Hugel J; Kish SJ J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119 [TBL] [Abstract][Full Text] [Related]
3. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530 [TBL] [Abstract][Full Text] [Related]
4. Fatality due to the use of a designer drug MDMA (Ecstasy). Kłys M; Rojek S; Woźniak K; Rzepecka-Woźniak E Leg Med (Tokyo); 2007 Jul; 9(4):185-91. PubMed ID: 17320458 [TBL] [Abstract][Full Text] [Related]
5. [Contaminants in illegal amphetamine. Basic contaminants in drug market 3,4-(methylenedioxy)methylamphetamine]. Verweij AM Arch Kriminol; 1991; 188(5-6):154-8. PubMed ID: 1686826 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of MDMA/MDA in both hair and urine in drug users. Han E; Yang W; Lee J; Park Y; Kim E; Lim M; Chung H Forensic Sci Int; 2005 Aug; 152(1):73-7. PubMed ID: 15939177 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS. Maresová V; Chadt J; Prikryl L Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795 [TBL] [Abstract][Full Text] [Related]
8. [Screening and detection of amphetamine derivatives in biological stains]. Schütz H; Gotta JC; Erdmann F; Weiler G Arch Kriminol; 2002; 210(1-2):22-7. PubMed ID: 12365331 [TBL] [Abstract][Full Text] [Related]
9. Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry. Mortier KA; Dams R; Lambert WE; De Letter EA; Van Calenbergh S; De Leenheer AP Rapid Commun Mass Spectrom; 2002; 16(9):865-70. PubMed ID: 11948818 [TBL] [Abstract][Full Text] [Related]
10. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Meyer MR; Peters FT; Maurer HH Toxicol Lett; 2009 Oct; 190(1):54-60. PubMed ID: 19576971 [TBL] [Abstract][Full Text] [Related]
11. High performance liquid chromatographic assays of the illicit designer drug "Ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding. Garrett ER; Seyda K; Marroum P Acta Pharm Nord; 1991; 3(1):9-14. PubMed ID: 1677250 [TBL] [Abstract][Full Text] [Related]
12. Stereoselective disposition: enantioselective quantitation of 3,4-(methylenedioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry. Lim HK; Su Z; Foltz RL Biol Mass Spectrom; 1993 Jul; 22(7):403-11. PubMed ID: 8102882 [TBL] [Abstract][Full Text] [Related]
13. Sensitive determination of MDMA and its metabolite MDA in rat blood and brain microdialysates by HPLC with fluorescence detection. Tomita M; Nakashima MN; Wada M; Nakashima K Biomed Chromatogr; 2007 Oct; 21(10):1016-22. PubMed ID: 17474141 [TBL] [Abstract][Full Text] [Related]
14. [Contamination of illegal amphetamine. Hydrastatinine as a contaminant in 3,4-(methylenedioxy)methylamphetamine]. Verweij AM Arch Kriminol; 1991; 188(1-2):54-7. PubMed ID: 1953248 [TBL] [Abstract][Full Text] [Related]
15. In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques. Lim HK; Foltz RL Biol Mass Spectrom; 1991 Nov; 20(11):677-86. PubMed ID: 1686830 [TBL] [Abstract][Full Text] [Related]
16. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats. Matsushima K; Nagai T; Kamiyama S J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966 [TBL] [Abstract][Full Text] [Related]
17. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity]. Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497 [TBL] [Abstract][Full Text] [Related]
18. Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair. Wu YH; Lin KL; Chen SC; Chang YZ J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):192-202. PubMed ID: 18585989 [TBL] [Abstract][Full Text] [Related]
19. Measurement of 3,4-MDMA and related amines in diagnostic and forensic laboratories. Skrinska VA; Gock SB Clin Lab Sci; 2005; 18(2):119-23. PubMed ID: 15916245 [TBL] [Abstract][Full Text] [Related]
20. Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine. Clauwaert KM; Van Bocxlaer JF; De Letter EA; Van Calenbergh S; Lambert WE; De Leenheer AP Clin Chem; 2000 Dec; 46(12):1968-77. PubMed ID: 11106329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]